Table 2.
Treatment group | Atomoxetine (n = 9) | Paroxetine (n = 10)a | Total venlafaxine and ODV (n = 10) | |||
---|---|---|---|---|---|---|
Dose level | Plasma level mean (ng/mL ± SD) | Plasma level range (ng/mL) | Plasma level mean (ng/mL ± SD) | Plasma level range (ng/mL) | Plasma level mean (ng/mL ± SD) | Plasma level range (ng/mL) |
I | 114 (70) | 33–235 | 17 (15) | 0–52 | 101 (69) | 0–224 |
II | 106 (50) | 0–160 | 38 (20) | 10–66 | 242 (115) | 107–497 |
III | 198 (90) | 50–462 | 61 (22) | 33–91 | 376 (143) | 164–580 |
IV | 184 (101) | 54–325 | 81(28) | 40–119 | 472 (243) | 159–849 |
Abbreviation: ODV, O-desmethyl-venlafaxine.
a Data for 1 patient not included due to a detection issue (see results section).